[Diagnosis, clinical feature and treatment of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis].
Nakayama
Hisanori
H
Department of Rheumatology, National Hospital Organization, Sagamihara Hospital.
D019386:Alendronate / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000150:complications / Q000188:drug therapy*; D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D005938:Glucocorticoids / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D010010:Osteoclasts / Q000502:physiology; D010024:Osteoporosis / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D053245:RANK Ligand; D016032:Randomized Controlled Trials as Topic; D016103:Spinal Fractures / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control
D050071:Bone Density Conservation Agents; D005938:Glucocorticoids; D053245:RANK Ligand; D019386:Alendronate